Literature DB >> 25343954

Renal hyperfiltration as a novel marker of all-cause mortality.

Minseon Park1, Eunsil Yoon2, Youn-Hee Lim3, Ho Kim3, Jinwook Choi4, Hyung-Jin Yoon5.   

Abstract

Although renal hyperfiltration (RHF) or an abnormal increase in GFR has been associated with many lifestyles and clinical conditions, including diabetes, its clinical consequence is not clear. RHF is frequently considered to be the result of overestimating true GFR in subjects with muscle wasting. To evaluate the association between RHF and mortality, 43,503 adult Koreans who underwent voluntary health screening at Seoul National University Hospital between March of 1995 and May of 2006 with baseline GFR≥60 ml/min per 1.73 m(2) were followed up for mortality until December 31, 2012. GFR was estimated with the Chronic Kidney Disease Epidemiology Collaboration creatinine equation, and RHF was defined as GFR>95th percentile after adjustment for age, sex, muscle mass, and history of diabetes and/or hypertension medication. Muscle mass was measured with bioimpedance analysis at baseline. During the median follow-up of 12.4 years, 1743 deaths occurred. The odds ratio of RHF in participants with the highest quartile of muscle mass was 1.31 (95% confidence interval [95% CI], 1.11 to 1.54) compared with the lowest quartile after adjusting for confounding factors, including body mass index. The hazard ratio of all-cause mortality for RHF was 1.37 (95% CI, 1.11 to 1.70) by Cox proportional hazards model with adjustment for known risk factors, including smoking. These data suggest RHF may be associated with increased all-cause mortality in an apparently healthy population. The possibility of RHF as a novel marker of all-cause mortality should be confirmed.
Copyright © 2015 by the American Society of Nephrology.

Entities:  

Keywords:  CKD; GFR; epidemiology and outcomes; glomerular hyperfiltration; mortality

Mesh:

Year:  2014        PMID: 25343954      PMCID: PMC4446866          DOI: 10.1681/ASN.2014010115

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  34 in total

1.  A critical appraisal for definition of hyperfiltration.

Authors:  Gere Sunder-Plassmann; Walter H Hörl
Journal:  Am J Kidney Dis       Date:  2004-02       Impact factor: 8.860

Review 2.  Glomerular hyperfiltration: definitions, mechanisms and clinical implications.

Authors:  Imed Helal; Godela M Fick-Brosnahan; Berenice Reed-Gitomer; Robert W Schrier
Journal:  Nat Rev Nephrol       Date:  2012-02-21       Impact factor: 28.314

3.  Estimating glomerular filtration rate from serum creatinine and cystatin C.

Authors:  Lesley A Inker; Christopher H Schmid; Hocine Tighiouart; John H Eckfeldt; Harold I Feldman; Tom Greene; John W Kusek; Jane Manzi; Frederick Van Lente; Yaping Lucy Zhang; Josef Coresh; Andrew S Levey
Journal:  N Engl J Med       Date:  2012-07-05       Impact factor: 91.245

4.  Lean body mass and body fat distribution in participants with chronic low back pain.

Authors:  Y Toda; N Segal; T Toda; T Morimoto; R Ogawa
Journal:  Arch Intern Med       Date:  2000-11-27

5.  Association of low aerobic fitness with hyperfiltration and albuminuria in men.

Authors:  Minseon Park; Youngjin Ko; Sang Hoon Song; Seongbeen Kim; Hyung-Jin Yoon
Journal:  Med Sci Sports Exerc       Date:  2013-02       Impact factor: 5.411

Review 6.  The role of the renin-angiotensin-aldosterone system in obesity-related renal diseases.

Authors:  Christiane Rüster; Gunter Wolf
Journal:  Semin Nephrol       Date:  2013-01       Impact factor: 5.299

7.  Predicting diabetic nephropathy in insulin-dependent patients.

Authors:  C E Mogensen; C K Christensen
Journal:  N Engl J Med       Date:  1984-07-12       Impact factor: 91.245

8.  The effects of weight loss on renal function in patients with severe obesity.

Authors:  Avry Chagnac; Tali Weinstein; Michal Herman; Judith Hirsh; Uzi Gafter; Yaacov Ori
Journal:  J Am Soc Nephrol       Date:  2003-06       Impact factor: 10.121

Review 9.  Epidemiology and natural history of patients with NAFLD.

Authors:  Neeraj Bhala; Ramy Younes; Elisabetta Bugianesi
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

Review 10.  Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis.

Authors:  Bakhtawar K Mahmoodi; Kunihiro Matsushita; Mark Woodward; Peter J Blankestijn; Massimo Cirillo; Takayoshi Ohkubo; Peter Rossing; Mark J Sarnak; Bénédicte Stengel; Kazumasa Yamagishi; Kentaro Yamashita; Luxia Zhang; Josef Coresh; Paul E de Jong; Brad C Astor
Journal:  Lancet       Date:  2012-09-24       Impact factor: 79.321

View more
  38 in total

1.  Midterm eGFR and Adverse Pregnancy Outcomes: The Clinical Significance of Gestational Hyperfiltration.

Authors:  Sehoon Park; Seung Mi Lee; Joong Shin Park; Joon-Seok Hong; Ho Jun Chin; Ki Young Na; Dong Ki Kim; Kook-Hwan Oh; Kwon Wook Joo; Yon Su Kim; Hajeong Lee
Journal:  Clin J Am Soc Nephrol       Date:  2017-06-13       Impact factor: 8.237

2.  Association of CKD with Incident Tuberculosis.

Authors:  Sehoon Park; Soojin Lee; Yaerim Kim; Yeonhee Lee; Min Woo Kang; Semin Cho; Kyungdo Han; Seoung Seok Han; Hajeong Lee; Jung Pyo Lee; Kwon Wook Joo; Chun Soo Lim; Yon Su Kim; Dong Ki Kim
Journal:  Clin J Am Soc Nephrol       Date:  2019-06-06       Impact factor: 8.237

3.  Alcohol consumption and the risk for renal hyperfiltration in the general Chinese population.

Authors:  M Lin; Q Su; H Huang; Y Zheng; J Wen; J Yao; J Liang; L Li; W Lin; L Lin; J Lu; Y Bi; W Wang; G Ning; G Chen
Journal:  Eur J Clin Nutr       Date:  2016-11-02       Impact factor: 4.016

4.  A predictive model of progressive chronic kidney disease in idiopathic nephrotic syndrome.

Authors:  Ana Carmen Quaresma Mendonça; Eduardo Araújo Oliveira; Brunna Pinto Fróes; Lauro Damasceno Carvalho Faria; Juliana Silva Pinto; Maira Melo Ibrahim Nogueira; Gabriella Oliveira Lima; Priscila Isa Resende; Natália Silva Assis; Ana Cristina Simões E Silva; Sérgio Veloso Brant Pinheiro
Journal:  Pediatr Nephrol       Date:  2015-06-18       Impact factor: 3.714

5.  Self-reported sleep duration and daytime napping are associated with renal hyperfiltration in general population.

Authors:  Miao Lin; Qing Su; Junping Wen; Shichao Wei; Jin Yao; Huibin Huang; Jixing Liang; Liantao Li; Wei Lin; Lixiang Lin; Jieli Lu; Yufang Bi; Weiqing Wang; Guang Ning; Gang Chen
Journal:  Sleep Breath       Date:  2017-02-26       Impact factor: 2.816

6.  Sex Differences in Age-Related Loss of Kidney Function.

Authors:  Toralf Melsom; Jon Viljar Norvik; Inger Therese Enoksen; Vidar Stefansson; Ulla Dorte Mathisen; Ole Martin Fuskevåg; Trond G Jenssen; Marit D Solbu; Bjørn O Eriksen
Journal:  J Am Soc Nephrol       Date:  2022-08-17       Impact factor: 14.978

7.  Residual Associations of Inflammatory Markers with eGFR after Accounting for Measured GFR in a Community-Based Cohort without CKD.

Authors:  Jørgen Schei; Vidar T N Stefansson; Ulla Dorte Mathisen; Bjørn O Eriksen; Marit D Solbu; Trond G Jenssen; Toralf Melsom
Journal:  Clin J Am Soc Nephrol       Date:  2015-12-14       Impact factor: 8.237

8.  Role of Heart Rate Variability in Association Between Glomerular Hyperfiltration and All-Cause Mortality.

Authors:  Hao-Chih Chang; Chi-Jung Huang; Albert C Yang; Hao-Min Cheng; Shao-Yuan Chuang; Wen-Chung Yu; Chern-En Chiang; Chen-Huan Chen; Shih-Hsien Sung
Journal:  J Am Heart Assoc       Date:  2021-12-10       Impact factor: 5.501

9.  Renal Function Trajectories in Patients with Prior Improved eGFR Slopes and Risk of Death.

Authors:  Yan Xie; Benjamin Bowe; Hong Xian; Sumitra Balasubramanian; Ziyad Al-Aly
Journal:  PLoS One       Date:  2016-02-22       Impact factor: 3.240

10.  The Association of Posttraumatic Stress Disorder With Longitudinal Change in Glomerular Filtration Rate in World Trade Center Responders.

Authors:  Farrukh M Koraishy; Steven G Coca; Beth E Cohen; Jeffery F Scherrer; Frank Mann; Pei-Fen Kuan; Benjamin J Luft; Sean A P Clouston
Journal:  Psychosom Med       Date:  2021 Nov-Dec 01       Impact factor: 4.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.